Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application

Real-Time Quote  
Real-Time Quote Not Available Why not?
Real-Time Quote Only available during pre-market and regular market hours. about
  • Day Low  25.88 09:30 AM EDT  
    Day High 26.80 11:01 AM EDT
    Range 0.92  
    Volume 5.51 M  
    30-Day Avg Vol 2.70 M
    Difference 103.96%  
    Market Cap 2.48 B  
    Mkt Cap Chg -1.91 M  
    Shares Out 95.50 M  
    % Shrs Traded 5.77%  
    1yr EPS Est 1.349  
    52-Wk Low 25.34 7/7/08
    52-Wk High 47.08 3/31/09
    Range 21.74  
    Prev Close 26.02 7/1/09  
    Today's Open 26.12  
    Change 0.38%
    Dividend (TTM) 0.00  
    Div Yield (TTM) 0.00%
    Ex-Div Date
    Div Date
    Short Interest 6.52 M

    Performance Details

    Revenue (LFY) 333.62 M  
    Earnings (LFY) 47.84 M  
    Earnings (MRQ) 25.32 M  
    Next Earn Est 0.239  
    Next Earnings 11/04/2009
    EPS (TTM) 1.32  
    1yr EPS Growth 2.59%  
    P/E Ratio (TTM) 19.55  
    P/E Ratio (Fwd) 19.00  
    PEG Ratio 0.76  
    Return on Equity 21.37  
    Beta 0.51  
    Sector Healthcare  
    Industry Drugs  
    Click icons above for more info
  • Set and Manage Alerts

    Alert me if
  • Blog Posts: MYGN

    Blogs are not currently available for mygn.

    View all blogs at BloggingStocks.

  • Related Information: MYGN

    Company Overview: MYGN

    There are a myriad of diseases out there, and Myriad Genetics is working to figure out which ones you will get. Its molecular diagnostic tests can determine a patient's risk for breast or ovarian cancer ... View Full Description

    Earnings Analysis: MYGN

    Analyst Consensus

    • Strong Buy
    • Buy
    • Hold
    • Sell
    • Strong Sell
    Earnings/Share(EPS) Estimate Actual Difference
    Next Quarter 0.239 8/25/09
    Last Quarter 0.24 3/31/09 0.25 3/31/09 0.01
    Beat
    2 Quarters Ago 0.162 12/31/08 0.215 12/31/08 0.053
    Beat

    Financials: MYGN

      Quarterly - 03/31/2009 Annual - 2008
    Total Revenue 87.49 M 333.63 M
    Gross Profit 76.26 M 301.29 M
    Operating Income 22.31 M 38.08 M
    Net Income 25.32 M 47.84 M